Bayer AG NA (BAYN HM) stock market data APIs
€27.6856
-0.32(-1.2%)
as of October 29, 2025
Try our APIs with
free plan!
Bayer AG NA Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BAYN.HM.
Prev. Close
27.6856
Open
27.3636
High
27.2986
Low
27.3636
52 wk Range
18.605-29.75
Market Cap
45 791 M
EPS
1.22
Dividends (Yield)
0.0497
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bayer AG NA data using free add-ons & libraries
Get Bayer AG NA Fundamental Data
Bayer AG NA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-08-08
- EPS/Forecast: 1.26
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bayer AG NA News
New
Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Medpace (MEDP) is a stock that can certainly grab the attention of many investors, b...
Inari Appoints Lisa Nunez Safarian Chief Executive Officer
Safarian also joins Flagship Pioneering, Founding Company of Inari, as CEO-Partner CAMBRIDGE, Mass., Oct. 29, 2025 /PRNewswire/ -- Inari, the SEEDesign™ company, and Flagship Pioneering, a scientif...
REGN Stock Up on Q3 Earnings Beat, Eylea HD Sales Increase
Regeneron Pharmaceuticals, Inc. REGN reported third-quarter 2025 adjusted earnings per share (EPS) of $11.83, which comfortably beat the Zacks Consensus Estimate of $9.44. However, the bottom line was...
Regeneron's Earnings Took A Big Tax Hit, And Still Pounded Forecasts
Regeneron stock advanced early Tuesday on better-than-expected third-quarter earnings despite a big tax hit. Continue Reading View Comments
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
